MedX Health Corp Stock

Equities

MDX

CA5850901037

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. 02:45:33 2024-04-24 pm EDT 5-day change 1st Jan Change
0.09 CAD -5.26% Intraday chart for MedX Health Corp +28.57% +50.00%
Sales 2021 563K 410K Sales 2022 511K 372K Capitalization 6.43M 4.69M
Net income 2021 -5M -3.64M Net income 2022 -5M -3.64M EV / Sales 2021 30.5 x
Net Debt 2021 2.47M 1.8M Net Debt 2022 4.86M 3.54M EV / Sales 2022 22.1 x
P/E ratio 2021
-2.71 x
P/E ratio 2022
-1.25 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 93.59%
More Fundamentals * Assessed data
Dynamic Chart
1 day-5.26%
1 week+28.57%
Current month+28.57%
1 month+38.46%
3 months+80.00%
6 months+50.00%
Current year+50.00%
More quotes
1 week
0.08
Extreme 0.08
0.11
1 month
0.06
Extreme 0.06
0.11
Current year
0.03
Extreme 0.025
0.11
1 year
0.03
Extreme 0.025
0.11
3 years
0.02
Extreme 0.02
0.19
5 years
0.02
Extreme 0.02
0.26
10 years
0.02
Extreme 0.02
0.33
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-04-24
Director of Finance/CFO - 22-04-28
Director/Board Member - 21-05-04
Members of the board TitleAgeSince
Director/Board Member 84 01-11-18
Chairman - 01-11-18
Director/Board Member - 21-05-04
More insiders
Date Price Change Volume
24-04-24 0.09 -5.26% 84,822
24-04-23 0.095 -5.00% 749,314
24-04-22 0.1 +5.26% 636,800
24-04-19 0.095 +18.75% 450,752
24-04-18 0.08 +14.29% 964,300

Delayed Quote Toronto S.E., April 24, 2024 at 02:45 pm EDT

More quotes
MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.
More about the company